2-(3-Isobutoxyphenyl)quinoline-4-carbohydrazide

Catalog No. :
ACLMMF909
CAS No. :
524733-57-1
Molecular Formula :
C20H21N3O2
Molecular Weight :
335.41

IUPAC Name:2-(3-isobutoxyphenyl)quinoline-4-carbohydrazide

2-(3-Isobutoxyphenyl)quinoline-4-carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$207.00Login to see priceInquiryInquiry
1g95%$519.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Isobutoxyphenyl)quinoline-4-carbohydrazide
IUPAC Name2-(3-isobutoxyphenyl)quinoline-4-carbohydrazide
MDL No.MFCD02375092
Molecular FormulaC20H21N3O2
Molecular Weight335.41
SMILESO=C(C1=CC(C2=CC=CC(OCC(C)C)=C2)=NC3=CC=CC=C13)NN
InChI KeyGACFTLVXJJSZEQ-UHFFFAOYSA-N
Synonym2-(3-ISOBUTOXYPHENYL)QUINOLINE-4-CARBOHYDRAZIDE;IVK/9675972;2-(3-isobutoxyphenyl)-4-quinolinecarbohydrazide;2-(3-isobutoxyphenyl)cinchoninohydrazide;2-[3-(2-methylpropoxy)phenyl]quinoline-4-carbohydrazide;4-Quinolinecarboxylic acid, 2-[3-(2-methylpropoxy)phenyl]-, hydrazide
CAS No.524733-57-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLMMF909 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLMMF909 route product structure diagram
    ACLMMF909524733-57-1
Inquiry

2. ACLMMF909 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLMMF909 route product structure diagram
    ACLMMF909524733-57-1
Inquiry

Comments (0)